PRA Health Sciences Inc. [NASDAQ: PRAH] gained 18.73% or 23.93 points to close at $151.66 with a heavy trading volume of 7231295 shares. The company report on February 25, 2021 that SHAREHOLDER ALERT: WeissLaw LLP Investigates PRA Health Sciences Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of PRA Health Sciences Inc. (“PRAH” or the “Company”) (NASDAQ: PRAH) in connection with the proposed cash-and-stock acquisition of the Company by ICON plc (NASDAQ GS: “ICLR”). Under the terms of the merger agreement, PRAH shareholders will receive $80.00 in cash and 0.4125 shares of stock for each share of PRAH common stock that they own, representing per-share merger consideration of approximately $166.05 based upon ICLR’s February 23, 2021 closing price of $208.62. Upon consummation of the deal, ICLR shareholders will own approximately 66 percent of the newly-combined company, leaving only 34% of the new company controlled by former PRAH shareholders. The transaction is valued at approximately $12 billion.
If you own PRAH shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:.
It opened the trading session at $147.78, the shares rose to $155.00 and dropped to $147.00, the range by which the price of stock traded the whole day. The daily chart for PRAH points out that the company has recorded 49.33% gains over the past six months. However, it is still -158.5% lower than its most recent low trading price.
If we look at the average trading volume of 272.92K shares, PRAH reached to a volume of 7231295 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about PRA Health Sciences Inc. [PRAH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PRAH shares is $127.42 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PRAH stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for PRA Health Sciences Inc. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on August 10, 2020. The new note on the price target was released on May 01, 2020, representing the official price target for PRA Health Sciences Inc. stock. On January 10, 2020, analysts decreased their price target for PRAH shares from 130 to 120.
The Average True Range (ATR) for PRA Health Sciences Inc. is set at 5.31, with the Price to Sales ratio for PRAH stock in the period of the last 12 months amounting to 3.07. The Price to Book ratio for the last quarter was 7.26, with the Price to Cash per share for the same quarter was set at 5.34. Price to Free Cash Flow for PRAH in the course of the last twelve months was 24.65 with Quick ratio for the last quarter at 1.10.
Trading performance analysis for PRAH stock
PRA Health Sciences Inc. [PRAH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.51. With this latest performance, PRAH shares gained by 15.44% in over the last four-week period, additionally plugging by 49.33% over the last 6 months – not to mention a rise of 59.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PRAH stock in for the last two-week period is set at 78.59, with the RSI for the last a single of trading hit 84.93, and the three-weeks RSI is set at 74.17 for PRA Health Sciences Inc. [PRAH]. The present Moving Average for the last 50 days of trading for this stock 125.73, while it was recorded at 131.97 for the last single week of trading, and 109.02 for the last 200 days.
PRA Health Sciences Inc. [PRAH]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and PRA Health Sciences Inc. [PRAH] shares currently have an operating margin of +11.96 and a Gross Margin at +24.84. PRA Health Sciences Inc.’s Net Margin is presently recorded at +7.93.
Return on Total Capital for PRAH is now 15.65, given the latest momentum, and Return on Invested Capital for the company is 10.73. Return on Equity for this stock inclined to 22.77, with Return on Assets sitting at 7.22. When it comes to the capital structure of this company, PRA Health Sciences Inc. [PRAH] has a Total Debt to Total Equity ratio set at 134.31. Additionally, PRAH Total Debt to Total Capital is recorded at 57.32, with Total Debt to Total Assets ending up at 41.30. Long-Term Debt to Equity for the company is recorded at 120.42, with the Long-Term Debt to Total Capital now at 51.39.
Reflecting on the efficiency of the workforce at the company, PRA Health Sciences Inc. [PRAH] managed to generate an average of $13,887 per employee. Receivables Turnover for the company is 4.98 with a Total Asset Turnover recorded at a value of 0.91.PRA Health Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.10.
PRA Health Sciences Inc. [PRAH]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, PRA Health Sciences Inc. posted 1.05/share EPS, while the average EPS was predicted by analysts to be reported at 1.01/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PRAH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for PRA Health Sciences Inc. go to 9.86%.
An analysis of insider ownership at PRA Health Sciences Inc. [PRAH]
There are presently around $9,461 million, or 98.91% of PRAH stock, in the hands of institutional investors. The top three institutional holders of PRAH stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 7,054,860, which is approximately -0.662% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 6,709,141 shares of the stock with an approximate value of $1.02 billion in PRAH stocks shares; and BLACKROCK INC., currently with $974.32 million in PRAH stock with ownership of nearly 0.463% of the company’s market capitalization.
Positions in PRA Health Sciences Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 147 institutional holders increased their position in PRA Health Sciences Inc. [NASDAQ:PRAH] by around 2,860,456 shares. Additionally, 131 investors decreased positions by around 2,240,805 shares, while 42 investors held positions by with 57,284,491 shares. The mentioned changes placed institutional holdings at 62,385,752 shares, according to the latest SEC report filing. PRAH stock had 35 new institutional investments in for a total of 527,073 shares, while 33 institutional investors sold positions of 664,132 shares during the same period.